News Quantified

CDNA – caredx, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

CareDx Announces VANTx™, an AI-Powered Clinical Data & Analytics Platform Built on CareDx's Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets [Yahoo! Finance]

CareDx Announces VANTx™, an AI-Powered Clinical Data & Analytics Platform Built on CareDx’s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets

CareDx (CDNA) was downgraded by Weiss Ratings from "hold (c-)" to "sell (d)".

CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CareDx (CDNA) had its "buy" rating reaffirmed by BTIG Research.

-4.1%

BEAT

13.8%

BEAT

-7.9%

BEAT

-10.7%

BEAT

Form 8-K/A CareDx, Inc. For: Feb 24

Form 10-K CareDx, Inc. For: Dec 31

Form 8-K CareDx, Inc. For: Feb 24

Form SCHEDULE 13G/A CareDx, Inc. Filed by: GAGNON SECURITIES LLC

Form SCHEDULE 13G CareDx, Inc. Filed by: STATE STREET CORP

Top News Gainers

3/13 CareDx Inc (NASDAQ: CDNA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 17.3%

4/6 CareDx Supports Launch of International COVID-19 Transplant Registry (C19TxR) 15.5%

5/8 Q1/2019 3/31/2019 EPS 0.050 ZacksConsensus -0.150 ActVsEst 0.200 - Beat 12.9%

1/13 Form 8-K CareDx, Inc. For: Jan 13 10.3%

4/14 CareDx Introduces AlloCell: Cell Therapy Surveillance 7.6%

9/11 CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 7.4%

10/2 Form 4 CareDx, Inc. For: Oct 01 Filed by: COURNOYER CHRISTINE 7.4%

5/1 CareDx Inc (NASDAQ: CDNA) had its price target lowered by analysts at Piper Sandler from $59.00 to $54.00. They now have an "overweight" rating on the stock. 7.4%

3/20 New AJT Publication: AlloSure Monitors First Patient Retransplanted After Anti-PD-L1 Cancer Therapy 7.0%

6/11 CareDx Inc (NASDAQ: CDNA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 6.6%

Top News Decliners

3/16 Form 4 CareDx, Inc. For: Mar 16 Filed by: Maag Peter -19.3%

7/15 Form 4/A CareDx, Inc. For: Jun 17 Filed by: Goldberg Michael -12.9%

8/3 INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against CareDx, Inc. -12.4%

10/31 Form 8-K CareDx, Inc. For: Oct 31 -12.0%

11/4 CareDx Advances Patient Care with AlloSure 3.0 -10.7%

3/12 CareDx Joins National Kidney Foundation on World Kidney Day to Support Kidney Transplant Community -10.2%

6/21 Form 4 CareDx, Inc. For: Jun 20 Filed by: Bell Michael Brian -10.0%

8/8 Form 4 CareDx, Inc. For: Aug 06 Filed by: Seeto Reginald -9.0%

7/16 Glancy Prongay & Murray LLP Announces Investigation on Behalf of CareDx, Inc. Investors (CDNA) -8.4%

10/16 CareDx Inc (NASDAQ: CDNA) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -8.3%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day